Prognostic Significance of VEGF Expression in Correlation With COX-2, Microvessel Density, and Clinicopathological Characteristics in Human Gastric Carcinoma-Reference-Cited by-同舟云学术

Prognostic Significance of VEGF Expression in Correlation With COX-2, Microvessel Density, and Clinicopathological Characteristics in Human Gastric Carcinoma

Published:2007-08-09 Issue:10 Volume:14 Page:2738-2747
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kolev Yanislav,Uetake Hiroyuki,Iida Satoru,Ishikawa Toshiaki,Kawano Tatsuyuki,Sugihara Kenichi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-007-9484-7.pdf

Reference35 articles.

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108

2. Lambert L, Guilloux A, Oshima A, et al. Incidence and mortality from stomach cancer in Japan, Slovenia and USA. Int J Cancer 2002;97:811–8

3. Liekens S, De Clercq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol 2001;61:253–70

4. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–57

5. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18:7908–16

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform;Cancers;2023-02-06

2. The Expression and Prognostic Significance of VEGF and CXCR4 in Gastric Cancer: Correlation with Angiogenesis, Lymphangiogenesis and Progression;Current Issues in Molecular Biology;2022-07-06

3. Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer;Gastroenterology;2021-12

4. Angiogenesis and lead (Pb): is there a connection?;Drug and Chemical Toxicology;2020-03-04

5. Leitlinienreport zur S3-Leitlinie Magenkarzinom – „Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs“;Zeitschrift für Gastroenterologie;2019-12